Search results (58)
« Back to PublicationsTPC1-dependent control of endosomal pH and transferrin uptake determines cellular iron status.
Journal article
Deutsch R. et al, (2026), Proc Natl Acad Sci U S A, 123
Allosteric switching of Ca2+ permeability in the lysosomal ion channel TPC2 underpins biased agonist activation.
Journal article
Mu Q. et al, (2026), EMBO J
Regulation of Ferroptosis Sensitivity in Hepatocellular Carcinoma Cells by Lysosomal Ion Channels TPC2 and TRPML1.
Journal article
Geisslinger F. et al, (2026), Antioxidants (Basel), 15
TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition.
Journal article
Weiden E-M. et al, (2026), EMBO J, 45, 2182 - 2209
Proton-selective conductance and gating of the lysosomal cation channel TMEM175.
Journal article
Schulze T. et al, (2026), Proc Natl Acad Sci U S A, 123
Direct measurements of luminal Ca2+ with endo-lysosomal GFP-aequorin reveal functional IP3 receptors.
Journal article
Calvo B. et al, (2025), J Cell Biol, 224
Physiological functions and pharmacological targeting of transient receptor potential channels.
Journal article
Chubanov V. et al, (2025), Pharmacol Rev, 77
TRPML2 channel modulation by PI(3,5)P₂ and small-molecule agonists controls endosomal vesicle dynamics.
Journal article
Gu Z-Q. et al, (2025), Biomed Pharmacother, 189
TRPML2 in distinct states reveals the activation and modulation principles of the TRPML family.
Journal article
Schmiege P. et al, (2025), Nat Commun, 16
Lysosomal TMEM165 controls cellular ion homeostasis and survival by mediating lysosomal Ca2+ import and H+ efflux.
Journal article
Chen R. et al, (2025), Nat Commun, 16
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson's disease.
Journal article
Gregori M. et al, (2025), J Cell Biol, 224
Unraveling pH Regulation of TMEM175, an Endolysosomal Cation Channel With a Role in Parkinson's Disease.
Journal article
Schulze T. et al, (2025), J Cell Physiol, 240
Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis.
Journal article
Abrahamian C. et al, (2024), Nat Commun, 15
